Chronic lymphocytic leukaemia (CLL) and CLL‐type monoclonal B‐cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing

The aim of this study was to screen for cell surface markers that could discriminate CLL‐type MBL from CLL or identify CLL cases likely to have stable disease.

[1]  B. Gu,et al.  Impaired Transendothelial Migration of B-CLL Lymphocytes: a Defect Linked to Low L-Selectin Expression , 2001, Leukemia & lymphoma.

[2]  Michael Hallek,et al.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.

[3]  Michael E. Williams.  Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia , 2008 .

[4]  I. Williams.  CCR6 and CCL20 , 2006, Annals of the New York Academy of Sciences.

[5]  Deborah A. Bowen,et al.  Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients , 2007, British journal of haematology.

[6]  Deborah A. Bowen,et al.  Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[8]  Paolo Ghia,et al.  Diagnostic criteria for monoclonal B‐cell lymphocytosis , 2005, British journal of haematology.

[9]  T. Shanafelt,et al.  CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential , 2008, British journal of haematology.

[10]  A. Rawstron,et al.  The biological and clinical relationship between CD5+23+ monoclonal B‐cell lymphocytosis and chronic lymphocytic leukaemia , 2007, British journal of haematology.

[11]  S. Richards,et al.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. , 2008, The New England journal of medicine.

[12]  G. Jenkins,et al.  B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. , 2008, Blood.

[13]  D. Rossi,et al.  The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors , 2009, British journal of haematology.

[14]  D. Oscier,et al.  CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. , 2002, Blood.

[15]  F. Buccisano,et al.  Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. , 2008, Blood.

[16]  U. Höpken,et al.  Role of Homeostatic Chemokine and Sphingosine‐1‐Phosphate Receptors in the Organization of Lymphoid Tissue , 2003, Annals of the New York Academy of Sciences.

[17]  S. Rosen.  Ligands for L-selectin: homing, inflammation, and beyond. , 2004, Annual review of immunology.